Analyst Reco. The Beauty Health Company

Equities

SKIN

US88331L1089

Real-time Estimate Cboe BZX Other stock markets 09:33:02 02/05/2024 pm IST			5-day change	1st Jan Change
3.325 ^USD	+4.89%		+8.17%	+6.43%

10/04	Beauty Health Names Sheri Lewis as Chief Supply Chain, Operations Officer	MT
09/04	The Beauty Health Company Announces Termination of Brad Hauser as Chief Operating Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Adjusts Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	14/03	MT
Stifel Raises Price Target on The Beauty Health to $4 From $3, Maintains Hold Rating	13/03	MT
TD Cowen Adjusts Price Target on The Beauty Health to $4 From $2.50, Maintains Market Perform Rating	13/03	MT
Piper Sandler Adjusts Beauty Health's Price Target to $3 From $2, Maintains Underweight Rating	13/03	MT
Jefferies Downgrades Beauty Health to Hold From Buy, Adjusts Price Target to $1.50 From $11	15/11	MT
Stifel Adjusts Beauty Health's Price Target to $3 From $8, Keeps Hold Rating	15/11	MT
TD Cowen Downgrades Beauty Health to Market Perform From Outperform, Cuts Price Target to $2.50 From $9	14/11	MT
The ideal scenario is becoming reality	14/11
Raymond James Downgrades Beauty Health to Underperform From Market Perform	14/11	MT
William Blair Downgrades Beauty Health to Market Perform From Outperform	14/11	MT
Canaccord Genuity Downgrades Beauty Health to Hold From Buy, Price Target is $2.50	14/11	MT
JPMorgan Downgrades Beauty Health to Underweight From Neutral	14/11	MT
Piper Sandler Downgrades Beauty Health to Underweight From Overweight, Adjusts Price Target to $2 From $12	14/11	MT
Canaccord Genuity Assumes The Beauty Health Company at Buy With $10 Price Target	25/23/25	MT
TD Cowen Adjusts Price Target on The Beauty Health to $9 From $15, Maintains Outperform Rating	10/23/10	MT
DA Davidson Adjusts Price Target on Beauty Health to $16.50 From $35, Maintains Buy Rating	10/23/10	MT
Stifel Downgrades The Beauty Health Company to Hold From Buy, Adjusts Price Target to $10 From $17	21/23/21	MT
JPMorgan Chase Adjusts Price Target on The Beauty Health to $12 From $13, Maintains Neutral Rating	26/23/26	MT
BNP Paribas Exane Upgrades The Beauty Health to Neutral From Underperform	20/23/20	MT
DA Davidson Adjusts Price Target on Beauty Health to $35 From $32, Keeps Buy Rating	01/23/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. The Beauty Health Company

Equities

SKIN

US88331L1089

Analyst Reco.

Filters